Clinical Trial Update: A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining L19TNF in combination with lomustine for glioblastoma at progression or recurrence; study is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• L19TNF
• Lomustine (Lomustine)

Snippet

Sponsor: Philogen S.p.A. | Conditions: Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING